Turner Syndrome is a rare chromosomal disorder of females characterized by short stature and the lack of sexual development at puberty. The following studies are being conducted at the NIH:
Genotype and Phenotype: This study provides state of the art clinical evaluation of the Turner syndrome phenotype and genomic analysis using new sequencing data. Participants must be 7 years or older.
Hormone Replacement Therapy (HRT): This randomized, placebo-controlled study seeks to determine the effects of an improved method of HRT in treating Turner syndrome. Participants must be 14 years or older.
These studies take place at the NIH Clinical Center in Bethesda, MD, nine miles north of Washington, DC. There is no charge to participate. Study-related tests and medications are provided at no cost. Travel may be paid for those who qualify.
For more information about this National Institutes of Health (NIH) study, go to www.cc.nih.gov, call (toll free) 1-866-411-1222 (TTY: 1-866-411-1010) or e-mail prpl@cc.nih.gov
Back
Read about events on Capitol Hill, funding for rare-disease research, and other topics of interest from NORD's office in Washington, DC.
